Sensory Restoration After DIEP Flap Neurotization
Primary Purpose
Breast Cancer, Breast Reconstruction, Sensory Restoration
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
DIEP Flap Neurotization
Sponsored by

About this trial
This is an interventional treatment trial for Breast Cancer
Eligibility Criteria
Inclusion Criteria:
All patients presenting to Johns Hopkins who have had or will have mastectomy (therapeutic or prophylactic) and are planning to undergo unilateral mastectomy followed by breast reconstruction with autologous deep inferior epigastric perforator flap (DIEP) will be included.
These patients will then be randomized in either of two treatment modalities:
- Treatment Modality 1: Breast reconstruction with DIEP flap and neurotization.
- Treatment Modality 2: Breast reconstruction with DIEP flap but without neurotization.
- 18 years of age and older
- The patient is aware of the nature of her malignancy if a malignancy has been diagnosed; understands the study purpose, requirements, and risks; and is able and willing to sign an informed consent.
Exclusion Criteria:
- Autologous reconstruction where the flap is buried.
- Exclusion criteria will encompass any patient with: diabetic neuropathy, thyroid disorders, collagen vascular disease, alcoholism, pernicious anemia, or any other severe underlying peripheral neuropathy including chemotherapy-induced neuropathy or neuropathy induced by other medications.
- Pregnant or lactating women will be excluded from this study.
- Women with recurrent breast cancer will be excluded.
- Women with previous reconstructive procedures or who have previously undergone lumpectomy with radiation will be excluded.
Sites / Locations
- Johns Hopkins HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Neurotized Patients
Non-Neurotized Patients
Arm Description
Neurotization will be performed at the time of reconstruction.
No Neurotization will be performed at the time of reconstruction.
Outcomes
Primary Outcome Measures
12-month Breast sensation as assessed by the AcroValTM device
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Secondary Outcome Measures
Breast sensation at 6 months as assessed by the AcroValTM device
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Breast sensation at 18 months as assessed by the AcroValTM device
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Breast sensation at 24 months as assessed by the AcroValTM device
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Breast-specific health-related quality of life using the Breast-Q®
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Breast-specific health-related quality of life using the Breast-Q®
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Breast-specific health-related quality of life using the Breast-Q®
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Breast-specific health-related quality of life using the Breast-Q®
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
General health-related quality of life using the SF-12
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
General health-related quality of life using the SF-12
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
General health-related quality of life using the SF-12
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
General health-related quality of life using the SF-12
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Change in breast sensation as assessed by the AcroValTM device
Change in breast sensation from baseline, measured in cutaneous thresholds using the AcroValTM device.
Change in breast-specific health-related quality of life using the Breast-Q®
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Change in general health-related quality of life using the SF-12
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Full Information
NCT ID
NCT04533373
First Posted
August 26, 2020
Last Updated
December 9, 2022
Sponsor
Johns Hopkins University
Collaborators
Axogen Corporation
1. Study Identification
Unique Protocol Identification Number
NCT04533373
Brief Title
Sensory Restoration After DIEP Flap Neurotization
Official Title
The Effect of DIEP Flap Neurotization on Sensory Restoration After Breast Reconstruction
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
Axogen Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Common goals of breast reconstruction include obtaining satisfactory breast symmetry, softness, and appropriate size and shape. Advances in surgical techniques have prompted a new goal: achieving breast sensation after reconstructive surgery. This desire has led the surgical community to investigate operative techniques for achieving this goal. However, few studies have examined the effectiveness of breast sensory restoration.
Sensory nerves are nerves responsible for sensation from skin. When a sensory nerve is cut, sensation is lost to the area supplied by the nerve. In the case of Breast reconstruction this involves the nerves supplying the skin overlying breast(s). 'Neurotization' refers to regeneration of the nerve after it has been cut. This means that the cut nerve is being repaired in order to restore its function. In Neurotization this repair is carried out using a new "source". In this case, the investigators want to restore function of the nerves that supply the skin overlying the breast(s).
The investigators will be performing breast reconstruction using tissue from the patient's abdomen and transferring it to the chest wall to repair the mastectomy defect. Sensory function is restored by using the nerve that supplies the skin of this abdominal tissue (i.e the new "source") that is being transferred and attaching it to a nerve in the chest wall.
The Avance® Nerve graft is a nerve graft material that has been produced by Axogen, Inc. The graft is made by processing donated human nerves. This graft is used during neurotization to bridge the gap and join the nerve from the abdominal tissue to the nerve in the chest wall. The use of the graft helps the body to attach these 2 nerves and improves nerve repair.
When neurotization is done without the nerve graft there is a possibility that the surgeon may require extra nerve material to join the 2 nerves. Traditionally, in this case the surgeon would have to obtain a separate donor nerve from another part of the patient's body. This technique carries the risk of complications to part of the body that the separate donor nerve was obtained from - loss of sensation, infection or neuroma formation (an abnormal growth of nerve tissue that can cause pain, burning or tingling sensation, numbness). The Avance nerve graft avoids the need for the additional donor nerve and the possible complications associated with it.
The Avance® Nerve Graft is currently being used in some women during breast reconstruction surgery, however the effectiveness of this procedure in improving the restoration of sensation has not been proven.
Women undergoing reconstruction of one breast and at the same time using the women's own tissue as part of standard clinical care, may join.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Breast Reconstruction, Sensory Restoration
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
156 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Neurotized Patients
Arm Type
Experimental
Arm Description
Neurotization will be performed at the time of reconstruction.
Arm Title
Non-Neurotized Patients
Arm Type
No Intervention
Arm Description
No Neurotization will be performed at the time of reconstruction.
Intervention Type
Procedure
Intervention Name(s)
DIEP Flap Neurotization
Intervention Description
We will be performing breast reconstruction using tissue from the patient's abdomen and transferring it to the chest wall to repair the mastectomy defect. Sensory function is restored by using the nerve that supplies the skin of this abdominal tissue (i.e the new "source") that is being transferred and attaching it to a nerve in the chest wall.
Primary Outcome Measure Information:
Title
12-month Breast sensation as assessed by the AcroValTM device
Description
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Time Frame
12-months after DIEP Flap neurotization
Secondary Outcome Measure Information:
Title
Breast sensation at 6 months as assessed by the AcroValTM device
Description
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Time Frame
6 months after DIEP flap breast reconstruction
Title
Breast sensation at 18 months as assessed by the AcroValTM device
Description
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Time Frame
18 months after DIEP flap breast reconstruction
Title
Breast sensation at 24 months as assessed by the AcroValTM device
Description
Breast sensation, measured in cutaneous thresholds using the AcroValTM device.
Time Frame
24 months after DIEP flap breast reconstruction
Title
Breast-specific health-related quality of life using the Breast-Q®
Description
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Time Frame
6 months after DIEP flap breast reconstruction
Title
Breast-specific health-related quality of life using the Breast-Q®
Description
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Time Frame
12 months after DIEP flap breast reconstruction
Title
Breast-specific health-related quality of life using the Breast-Q®
Description
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Time Frame
18 months after DIEP flap breast reconstruction
Title
Breast-specific health-related quality of life using the Breast-Q®
Description
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Time Frame
24 months after DIEP flap breast reconstruction
Title
General health-related quality of life using the SF-12
Description
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Time Frame
6 months after DIEP flap breast reconstruction
Title
General health-related quality of life using the SF-12
Description
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Time Frame
12 months after DIEP flap breast reconstruction
Title
General health-related quality of life using the SF-12
Description
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Time Frame
18 months after DIEP flap breast reconstruction
Title
General health-related quality of life using the SF-12
Description
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Time Frame
24 months after DIEP flap breast reconstruction
Title
Change in breast sensation as assessed by the AcroValTM device
Description
Change in breast sensation from baseline, measured in cutaneous thresholds using the AcroValTM device.
Time Frame
Baseline, 6, 12, 18 and 24 months after DIEP flap breast reconstruction
Title
Change in breast-specific health-related quality of life using the Breast-Q®
Description
The Breast-Q® is a validated patient reported outcomes questionnaire used to assess Breast specific patient satisfaction and Health-related quality of life. The Breast-Q is comprised of 2 domains - i) Satisfaction domains and ii) Well-being domains, which are further divided into sub-domains. We will be using 3 satisfaction sub-domains:
i) Satisfaction with breasts ii) Satisfaction with Nipple iii) Satisfaction with outcome
and 3 well-being sub-domains:
i) Psychosocial well-being ii) Sexual well-being and iii) Physical well-being
Each sub-domain will be scored on a scale of 0-100, where higher scores will indicate higher satisfaction.
Time Frame
Baseline, 6, 12, 18, and 24 months after DIEP flap breast reconstruction
Title
Change in general health-related quality of life using the SF-12
Description
The SF-12 is a multipurpose short form (SF) survey with 12 questions, all selected from the SF-36 Health Survey. It has 2 components - i) Physical Health Composite score and ii) Mental Health Composite score. Each composite score is marked on a scale of 0-100, where a higher score indicates higher quality of life.
Time Frame
Baseline, 6, 12, 18, and 24 months after DIEP flap breast reconstruction
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients presenting to Johns Hopkins who have had or will have mastectomy (therapeutic or prophylactic) and are planning to undergo unilateral mastectomy followed by breast reconstruction with autologous deep inferior epigastric perforator flap (DIEP) will be included.
These patients will then be randomized in either of two treatment modalities:
Treatment Modality 1: Breast reconstruction with DIEP flap and neurotization.
Treatment Modality 2: Breast reconstruction with DIEP flap but without neurotization.
18 years of age and older
The patient is aware of the nature of her malignancy if a malignancy has been diagnosed; understands the study purpose, requirements, and risks; and is able and willing to sign an informed consent.
Exclusion Criteria:
Autologous reconstruction where the flap is buried.
Exclusion criteria will encompass any patient with: diabetic neuropathy, thyroid disorders, collagen vascular disease, alcoholism, pernicious anemia, or any other severe underlying peripheral neuropathy including chemotherapy-induced neuropathy or neuropathy induced by other medications.
Pregnant or lactating women will be excluded from this study.
Women with recurrent breast cancer will be excluded.
Women with previous reconstructive procedures or who have previously undergone lumpectomy with radiation will be excluded.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rafael Tinogco
Phone
443-287-6012
Email
rtiongc1@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Carisa M Cooney, MPH
Phone
443-287-4629
Email
ccooney3@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gedge D Rosson, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Hospital
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rafael Tiongco
Email
rtiongc1@jhmi.edu
First Name & Middle Initial & Last Name & Degree
Carisa M Cooney, MPH
Email
ccooney3@jhmi.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Sensory Restoration After DIEP Flap Neurotization
We'll reach out to this number within 24 hrs